Home

Warburg Pincus Partners GP LLC

CIK 1621224 · last filed 2026-03-10

Warburg Pincus Partners GP LLC is a corporate insider who has filed 13 SEC Form 4 insider transactions across 7 companies since 2014. The most recent filing shows the insider sold $1.83B of SHC on Mar 10, 2026. Across all open-market trades the lifetime net is −$5.15B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $606.9M across reported positions. The firm reports its address in New York, NY. 118 SEC filings were submitted jointly with PINCUS & CO. WARBURG.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$606.92M

Companies

7

Total Filings

13

Lifetime Open-Market Net

-$5.15B

Filer Profile

Reported Address
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY 10017
Phone
(212) 878-0600
State of Incorporation
DE
Related Filers
PINCUS & CO. WARBURG — 118 joint filings, latest 2026-05-15
Warburg Pincus Partners, L.P. — 105 joint filings, latest 2021-04-15
WARBURG PINCUS LLC — 85 joint filings, latest 2026-05-15
WPP GP LLC — 85 joint filings, latest 2021-04-15
Warburg Pincus X GP L.P. — 77 joint filings, latest 2021-04-15
Warburg Pincus X, L.P. — 77 joint filings, latest 2021-04-15
CHARLES R KAYE — 70 joint filings, latest 2020-01-14
Joseph P. Landy — 64 joint filings, latest 2019-11-13
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SHC Director 19,102,952 $18.90 $361.05M -$3.10B 2 2026-03-10
CRWD Director 271,000 $213.10 $57.75M $0 1 2019-12-17
Silk Road Medical Inc (SILK) Delisted 10%+ Owner 7,406,301 $27.49 $203.60M -$223.97M 1 2019-08-15
AR Director 0 $39.41 $0 -$794.41M 2 2019-06-12
BPI Director 7,562,890 $24.87 $188.12M -$130.75M 1 2017-08-18
Vital Energy, Inc. (LPI) Delisted 10%+ Owner 3,948,078 $48.09 $189.86M $0 2 2017-02-24
Endurance International Group Holdings, Inc. (EIGI) Delisted Director 37,112,844 — — -$894.45M 4 2016-09-16

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-10 SHC Sell (S) −120,000,000 -$1.83B EDGAR
2025-12-05 SHC Sell (S) −77,760,000 -$1.27B EDGAR
2019-12-17 CRWD Mixed +677,500 $0 EDGAR
2019-08-15 Silk Road Medical Inc (SILK) Delisted Sell (S) −5,670,000 -$223.97M EDGAR
2019-06-12 AR Sell (S) −128,753,520 -$794.41M EDGAR
2019-03-01 AR Other (J) −140,118,968 $0 EDGAR
2017-08-18 BPI Sell (S) −14,527,765 -$130.75M EDGAR
2017-02-24 Vital Energy, Inc. (LPI) Delisted Other (J) −99,999,810 $0 EDGAR
2016-09-16 Endurance International Group Holdings, Inc. (EIGI) Delisted Buy (P) +15,995,000 $137.85M EDGAR
2016-08-19 Endurance International Group Holdings, Inc. (EIGI) Delisted Buy (P) +3,630,000 $27.89M EDGAR
Showing 1–10 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.